secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-06-15T20:30:16+00:00
Accession:  0001493152-26-028699
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics shareholders approve reverse stock split and warrant issuances at annual meeting
--------------------------------------------------------------------------------

- Stockholders elected Lisa M. Giles and Rick S. Greene as Class II directors for three-year terms.
- Ratified Crowe LLP as independent auditor for FY2026 with 2,536,919 for, 1,748 against.
- Approved reverse stock split in range 1:5 to 1:20 to maintain Nasdaq listing.
- Approved issuance of up to 2,477,292 shares upon exercise of Common Warrants at $0.6055.
- Approved repricing of 3,020,410 existing warrants to $0.6055 per share exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226028699/0001493152-26-028699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226028699/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer